Cargando…
Development of a sandwich ELISA to detect circulating, soluble IRAP as a potential disease biomarker
There is growing interest in the use of the enzyme, insulin regulated aminopeptidase (IRAP), as a biomarker for conditions such as cardio-metabolic diseases and ischemic stroke, with upregulation in its tissue expression in these conditions. However, quantification of circulating IRAP has been hampe...
Autores principales: | Vear, Anika, Thalmann, Claudia, Youngs, Kristina, Hannan, Natalie, Gaspari, Tracey, Chai, Siew Yeen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673851/ https://www.ncbi.nlm.nih.gov/pubmed/38001104 http://dx.doi.org/10.1038/s41598-023-44038-1 |
Ejemplares similares
-
Is There an Interplay Between the Functional Domains of IRAP?
por: Vear, Anika, et al.
Publicado: (2020) -
Structural Basis of Inhibition of Human Insulin-Regulated
Aminopeptidase (IRAP) by Aryl Sulfonamides
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2018) -
Characterization of a sandwich ELISA for quantification of total human soluble neuropilin‐1
por: Gadermaier, Elisabeth, et al.
Publicado: (2019) -
Flow-injection sandwich ELISA for bioprocess monitoring
por: Rhee, Jong Il, et al.
Publicado: (1999) -
Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?
por: Trocmé, Candice, et al.
Publicado: (2021)